5AM Ventures reposted this
We are pleased to welcome Daniel Swisher as Chief Executive Officer! Dan joins the team with more than 30 years of leadership expertise in the #LifeSciences industry. During his career, he has led the advancement and commercialization of novel therapeutics in multiple therapeutic areas, including #neuroscience and #RareDiseases, and has significant experience in driving cross function, high-performing teams and relationship building. NodThera’s founder and interim CEO, Alan Watt, becomes our President and CSO, responsible for growing the Company’s R&D organisation and strengthening our world-leading position in #NLRP3 #inflammasome research. Find out more here: https://lnkd.in/d4vYKka7 #Appointment #NewHire #NeuroInflammation #WelcomeToTheTeam
Great to have you on board Dan!
Congratulations Alan Watt on the news roles and securing such a great CEO in Daniel Swisher for @Nodthera
Welcome Dan ! look forward to working together
Great news!
C-Suite Biopharma Executive and Board Member
4moVery excited to be here with this outstanding team, science and growing data sets.